Weekly Intelligence · 11 articles

Vet Industry Intel: Aug 16 – Aug 22, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Funding & Investment (2) Leadership Changes (1) Regulatory & Policy (7) Industry News (1)

Funding & Investment

Aug 19, 2026 [9/10] businesswire_vet

Charlotte vet startup Petfolk closes $40M funding round - The Business Journals

Petfolk, a veterinary practice management software startup based in Charlotte, raised $40 million in a funding round.

Petfolk · The Business Journals | NC

Aug 19, 2026 [9/10] gnews_zoetis

Mitsubishi UFJ Asset Management Co. Ltd. Has $76.91 Million Stake in Zoetis Inc. $ZTS - MarketBeat

Mitsubishi UFJ Asset Management Co. Ltd. acquired a $76.91 million stake in Zoetis Inc., a major veterinary pharmaceutical company.

Mitsubishi UFJ Asset Management Co. Ltd. · Zoetis Inc. | NJ

Leadership Changes

Aug 17, 2026 [9/10] gnews_zoetis

GE HealthCare CFO Jay Saccaro Leaves for Expanded Role at Zoetis - The Healthcare Technology Report.

GE HealthCare CFO Jay Saccaro has left his position to take an expanded role at Zoetis, a major veterinary pharmaceutical company.

GE HealthCare · Zoetis · The Healthcare Technology Report

Regulatory & Policy

Aug 17, 2026 [10/10] fda_cvm

FDA Authorizes Simparica TRIO for Screwworm in Dogs - MyChesCo

The U.S. Food and Drug Administration has approved Simparica TRIO for the treatment of screwworm infestation in dogs.

FDA · Simparica TRIO

Aug 17, 2026 [9/10] fda_cvm

FDA approves an emergency drug for New World screwworm infestation in dogs - Baltimore Sun

The U.S. Food and Drug Administration has approved an emergency drug to treat New World screwworm infestation in dogs.

FDA | MD

Aug 22, 2026 [9/10] fda_cvm

FDA authorizes Simparica TRIO for emergency treatment of New World screwworm in dogs - Gulf Coast Media

The U.S. Food and Drug Administration has authorized the use of Simparica TRIO for emergency treatment of New World screwworm infestations in dogs.

FDA · Zoetis

Aug 18, 2026 [9/10] gnews_zoetis

How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA - simplywall.st

Zoetis announced a flat Q2 earnings outlook and received a new FDA Emergency Use Authorization, prompting investor reactions.

Zoetis · FDA

Aug 22, 2026 [9/10] fda_cvm

FDA authorizes Simparica TRIO for emergency treatment of New World screwworm in dogs - Gulf Coast Media

The FDA has authorized the use of Simparica TRIO for emergency treatment of New World screwworm infestations in dogs.

FDA · Gulf Coast Media

Aug 18, 2026 [9/10] gnews_zoetis

How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA - simplywall.st

Zoetis announced a flat Q2 earnings outlook and received a new FDA Emergency Use Authorization, prompting investor reactions.

Zoetis · FDA · simplywall.st

Aug 20, 2026 [9/10] fda_cvm

FDA Authorizes Emergency Drug To Help Treat New World Screwworm in Dogs - Newsweek

The U.S. Food and Drug Administration has authorized an emergency drug to treat New World Screwworm infestations in dogs.

FDA

Industry News

Aug 18, 2026 [8/10] gnews_idexx

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha

IDEXX Labs reports ongoing execution challenges, with valuation pressures impacting its performance.

IDEXX Labs

Most-mentioned this week

Zoetis (1)